H.R.413: To eliminate the 2-year delay in including oral-only ESRD-related drugs in the Medicare ESRD prospective payment system, as provided under section 632(b)(1) of the American Taxpayer Relief Act of 2012.

About This Bill

  • This bill was introduced in the 113th Congress
  • This bill is primarily about health
  • Introduced Jan. 23, 2013
  • Latest Major Action Feb. 8, 2013

Bill Sponsor

Bill Cosponsors

3 (2 Democrats, 1 Republican)

Bill Summary

Amends the American Taxpayer Relief Act of 2012 to eliminate the two-year delay (until January 1, 2016) of the authority of the Secretary of Health and Human Services (HHS) to implement oral-only End Stage Renal Disease (ESRD)-related drugs in the ESRD prospective payment system (PPS) under title XVIII (Medicare) of the Social Security Act. (Thus authorizes the Secretary to implement such drugs in the ESRD-PPS immediately.)

(Source: Library of Congress)

Bill Actions

Date Description
Feb. 8, 2013
Referred to the Subcommittee on Health.
Jan. 25, 2013
Referred to the Subcommittee on Health.
Jan. 23, 2013
Referred to House Ways and Means
Jan. 23, 2013
Referred to House Energy and Commerce
Jan. 23, 2013

Introduced in the House by Peter Welch (D-Vt.)

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page